Effectiveness Of BCG Vaccination in Prevention of Childhood Tuberculosis: A Prospective Study from Kishanganj, Bihar
Keywords:
BCG vaccine, efficacy, tuberculosisAbstract
Introduction: BCG vaccine has shown consistently high efficacy against childhood tubercular meningitis and miliary tuberculosis and other mycobacterial diseases. It is considered to be a safe vaccine with a low incidence of adverse effects. Efficacy of BCG vaccine found in different clinical trials is variable in different geography.
Objectives: Study was done to assess the efficacy of BCG vaccine.
Materials and Methods: All the children who were less than three years of age and were previously BCG vaccinated and not-vaccinated, were included in this study. A total of sixty (60) vaccinated children and sixty non-vaccinated children were selected. These children were followed up prospectively for 24 months, at the end of which, it was seen whether they developed tuberculosis or not.
Results: Out of these 60 children in both the cases and control groups, total number of BCG vaccinated children who developed TB were 4 (i.e. 6.6%) and total number of Non-BCG vaccinated children who developed TB were 12 (i.e. 20%). Thus, the efficacy of BCG vaccine calculated in our study was 67%.
Conclusion: Most studies in different parts of the world have shown that the efficacy of BCG vaccine varies from zero to eighty percent. This study favors the efficacy of BCG vaccine. This vaccination strategy will be favorable for our children. Creation of awareness among the parents and family members for an early administration of BCG vaccine after child birth can be recommended.
References
Seth V, Kabra SK. History of tuberculosis. Essentials of Tuberculosis in Children. 3rd edition. New Delhi. Jaypee Brothers Medical Publishers (P) Ltd. 2006. p5.
World Health organization. Global Vaccine Safety, immunization, Vaccine and Biologicals. Information Sheet. Observed Rate of Vaccine Reactions. Bacille Calmette-Guerin (BCG) Vaccine. New Delhi. India. WHO: 2012.p1.
Franco-Paredes C, Rouphael N, del Rio C, Santos-Preciado, JI. Vaccination strategies to prevent tu-berculosis in the new millennium: from BCG to new vaccine candidates. Int Society for Infectious Diseas-es 2006; 10:93-102.
World Health Organization. BCG vaccine. WHO posi-tion paper. Wkly Epidemiol Rec. 2004;79(4):27–38.
Andersen P, Doherty TM. Learning from BCG: De-signing a better tuberculosis vaccine. Discov Med. 2005;5(28):383-7.
Suri JC, Oommen AV, Sudha K. Indian Freeze Dried B.C.G. Vaccine—Its Properties and Ad-vantages. Ind. J. Tub 1971;18(2):48-53.
Kausar R. BCG (Bacilus Calmette Guerin). Indian J Practising Doctor 2005:2(3): 94-5.
Anderson P, Doherty TM. The success and failure of BCG implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3(8):656-62.
Turnbull FM, McIntyre PB, Achat HM, Wang H, Sta-pledon R, Gold M et al. National study of nadverse reactions after vaccination with bacille Calmette-Guérin. Clin Infect Dis. 2002;34(4):447-53.
Department of Health. Immunisation Against Infec-tious Disease: the green book.UK. Public Health Eng-land.2013.
Thilothammal N, Krishnamurthy PV, Runyan DK, Banu K. Does BCG vaccine prevent tuberculous meningitis? Arch Dis Child 1996; 74(2): 144–47.
Zodpey SP, Maldhure BR, Shrikhande SN, Tiwari RR. Effectiveness of bacillus of Calmette- Guerin (BCG) vaccination against tuberculous meningitis: a case-control study. J Indian Med Assoc. 1996 ;94(9):338-40.
Sharma RS, Srivastava DK, Singh AA, Kumaras-wamy RK, Mullick DN, Rungsung N et al.Epidemiological evaluation of BCG vaccine efficacy in Delhi.. J Commun Dis1989;21:200–6.
Kumar P, Kumar R, Srivastava KL, Kumar M . Pro-tective role of BCG vaccination against tuberculous meningitis in Indian children: A reappraisal. The Na-tional Medical Journal of India 2005;18(1):7-11.
Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 2004;291(17):2086-91.
Rezai MS, Khotaei G, Mamishi S, Kheirkhah M, Par-vaneh N. Disseminated Bacillus Calmette-Guérin in-fection after BCG vaccination. J Trop Pediatr. 2008;54(6):413-16.
Thayyil-Sudhan S, Kumar A, Singh M, Paul VK, Deorari AK. Safety and effectiveness of BCG vac-cination in preterm babies. Arch Dis Child Fetal Neo-natal Ed. 1999;81(1):64-6.
McShane H. Tuberculosis vaccines: beyond bacille Calmette-Guérin. Philos Trans R Soc Lond B Biol Sci. 2011;366(1579):2782-89.
Payne S, Townend J, Jasseh M, Lowe Jallow Y, Kampmann B. Achieving comprehensive childhood immunization: an analysis of obstacles and opportu-nities in The Gambia. Health Policy Plan. 2013;28(3) : doi:10.1093/heapol/czt004
Vadakepat P. National Guidelines on diagnosis and treatment of Pediatric Tuberculosis. RNTCP New Paediatric Guidelines .New Delhi. India.2012.
Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and mil-iary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22(6):1154-8.
Trunz BB, Fine P, Dye C.Effect of BCG vaccination on childhood tuberculous meningitis and miliary tu-berculosis worldwide: a meta-analysis and assess-ment of cost-effectiveness. Lancet. 2006;367(9517):1173-80.
Peeira SM, Barreto ML, Pilger D, Cruz AA, Sant'An-na C, Hijjar MA. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial. The Lancet Infectious Diseases 2012;12( 4):300 – 6.
Gergonne B.New evidence of long-term BCG vaccine efficacy. Euro Surveill. 2004;8(34):2532. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2532
Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ et al.Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a pro-spective community-based study. Lancet 2005;366(9495):1443-1451.
Haile M, Källenius G. Recent developments in tuberculosis vaccines. Curr Opin Infect Dis.2005;18(3):211-5.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
